Showing results (651-660 of 701) with videos related to

Sort By:
Pageof 71
Journal of the American College of Cardiology|April 30, 2025
Finerenone Reduces New-Onset Atrial Fibrillation Across the Spectrum of Cardio-Kidney-Metabolic Syndrome: The FINE-HEART Pooled AnalysisMaria A Pabon, Gerasimos Filippatos, Brian L Claggett, et al.
Scientific Reports|July 16, 2020
Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetesRuchi Jain, Türküler Özgümüş, Troels Mygind Jensen, et al.
Lancet (London, England)|June 5, 2026
Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY)Brendon L Neuen, Hiddo J L Heerspink, Vlado Perkovic, et al.
JACC. Heart Failure|June 12, 2025
Efficacy and Safety of Finerenone in Heart Failure With Preserved Ejection Fraction: A FINE-HEART AnalysisJohn W Ostrominski, Gerasimos Filippatos, Brian L Claggett, et al.
Diabetes Care|February 28, 2025
Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials of Heart Failure and Chronic Kidney DiseaseJohn W Ostrominski, Brian L Claggett, Zi Michael Miao, et al.
Nature Microbiology|July 31, 2025
Polypeptides synthesized by common bacteria in the human gut improve rodent metabolismYong Fan, Liwei Lyu, Ruben Vazquez-Uribe, et al.
Journal of the American College of Cardiology|June 3, 2026
Effects of Finerenone on Sudden Death Across the Cardio-Kidney-Metabolic Landscape: A FINE-HEART AnalysisAlberto Foà, Maria A Pabon, Gerasimos Filippatos, et al.
Journal of the American College of Cardiology|September 2, 2025
Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular-Kidney-Metabolic Disease: Pooled Participant-Level Analysis of Three Global TrialsJohn W Ostrominski, Josephine Harrington, Brian L Claggett, et al.
Pageof 71